Senior Medical Science Liaison (Southeast Region)

Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema , with our transfor mation into a fully integrated oncology company well underway , t op-line data from our lead program expected later this year , and our first potential commercial launch on the horizon. Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC. Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day. If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond . About the Role >>> Senior Medical Science Liaison, Southeast Region As the Senior Medical Science Liaison reporting to the Director, Medical Science Liaison, you will serve as a scientific expert and external representative for Olema. You will engage with key opinion leaders and healthcare providers to facilitate scientific exchange, communicate medical and clinical information, and support Olema's medical affairs objectives. This is a field-based role (Southeast Region) that requires 50% travel. Your work will primarily encompass: Identify, connect, cultivate and maintain relationships with key opinion leaders, healthcare professionals and researchers in both academic and community centers within the assigned territory Develop and execute territory engagement plans that aligned with medical affairs strategies to optimize impact in the field Provide medical and scientific insights to internal stakeholders to inform product development and strategy Facilitate and support new and ongoing clinical research in collaboration with medical and clinical operations teams (company-sponsored trials, investigator-initiated studies, and other collaborative initiatives) Serve as a trusted scientific and medical resource, providing accurate and updated information about Olema therapies and research externally Conduct medical education programs and presentations to healthcare professionals as needed to rel…